Dinesh Patel
Dinesh Patel has been at the forefront of biotechnology and pharmaceuticals in the Intermountain Region for the past two decades. He co-founded and served as Chairman and CEO of TheraTech, a biotechnology company that he took public and eventually sold for $350 million to Watson Pharmaceuticals (NYSE:WPI). Dr. Patel was also a co-founder and founding CEO and chairman of Salus Therapeutics, which was acquired by Genta (NASDAQ:GNTA) for $30 million in August 2003.
Dr. Patel is well known for his refreshing approach to positioning promising business ideas for the future. He serves on several boards, including the Utah Life Science Industries Association, and has won numerous awards, including the 1998 Entrepreneur of the Year Award (Mountain West Venture Group), the 1997 Scientific Technology and Development Pioneer of Progress Award (State of Utah) and the 1996 Governor's Medal for Science and Technology Award (State of Utah). Prior to vSpring, Dr. Patel was an active angel investor, having invested in 12 companies in the biotechnology and life sciences sectors.
Additional Information
No additional information has been added yet. Add a LinkedIn URL.
Invested In
No investments.